| Literature DB >> 25280635 |
Chunxi Han1, Jiahui Mai2, Tian Tian3, Yanxia He4, Jianxiang Liao1, Feiqiu Wen1, Xin Yi3, Yun Yang5.
Abstract
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a rare autosomal recessive neuromuscular disorder caused by mutations in the IGHMBP2 gene and characterized by life-threatening respiratory distress due to irreversible diaphragmatic paralysis between 6weeks and 6months of age. In this study, we describe a two-month-old boy who presented with hypertonia at first and developed to hypotonia progressively, which was in contrast to the manifestations reported previously. Bone tissue compromise was also observed as one of the unique symptoms. Muscle biopsy indicated mild myogenic changes. He was misdiagnosed until genetic screening to be confirmed as SMARD1. SMARD1 is a clinical heterogeneous disease and this case broadens our perception of its phenotypes.Entities:
Keywords: Bone tissue compromise; Diaphragmatic paralysis; Hypertonia; IGHMBP2; Spinal muscular atrophy with respiratory distress type 1 (SMARD1)
Mesh:
Substances:
Year: 2014 PMID: 25280635 DOI: 10.1016/j.braindev.2014.09.004
Source DB: PubMed Journal: Brain Dev ISSN: 0387-7604 Impact factor: 1.961